Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Her 2,500+ articles make science simple and empower readers to thrive on their own terms.
Somatostatin receptor ligand use in congenital hyperinsulinism Somatostatin treatment was first described in a child with CHI after 80% pancreatectomy (31), followed by use of a continuous subcutaneous infusion via a pump in a 6-month old infant with insulin excess (32)
When patients do report increased thirst while taking GLP-1 medications, it typically occurs as a secondary consequence rather than a direct drug effect
High and strong
Chhonker YS, Chandasana H, Bala V, Mukkavilli R, Kumar D, Vangala S, et al
US$ 29.55
US$ 24.65
US$ 26.60
US$ 20.88
US$ 29.18
US$ 29.31
US$ 26.01
